Journal List > J Korean Surg Soc > v.79(5) > 1011192

J Korean Surg Soc. 2010 Nov;79(5):399-404. Korean.
Published online November 12, 2010.
Copyright © 2010 The Korean Surgical Society
The Experience of Non-surgical Treatment for Infantile Hepatic Hemangioendothelioma
So-Hyun Nam, M.D., Jeong-Ik Park, M.D., Dae-Yeon Kim, M.D.,1 Seong-Chul Kim, M.D.,1 and In-Koo Kim, M.D.1
Department of Surgery, Inje University Haeundae Paik Hospital, Busan, Korea.
1Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Corresponding author (Email: )
Received April 16, 2010; Accepted July 26, 2010.



Hepatic hemangioendothelioma (HET) is a rare benign vascular tumor in infants. The clinical manifestations are variable from asymptomatic to life-threatening heart failure or Kasabach-Merritt syndrome (KM SD). We report our non-surgical treatment experience for infantile HET.


We analyzed 15 infants (5 males, 10 females) of HET retrospectively, from January 1989 to December 2007.


All except 2 were full-term babies and median birth weight was 3,140 g. The median age at diagnosis was 15 days of life (0~157 days). Three of 5 patients diagnosed prenatally presented heart failure symptoms and the remaining 2 showed KM SD. Among 6 neonates, 3 showed cyanosis due to congestive heart failure. Nine patients showed multiple nodules at both liver lobes. Three asymptomatic patients were followed with radiologic examinations, thus HETs regressed spontaneously in two and decreased in one. Four cases that showed hepatomegaly or increase in size of subcutaneous hemangioma, were treated with prednisolone. All patients improved from tumor related symptoms and tumor size decreased. Four patients (2 patients of heart failure, 1 with rapid progressive hepatomegaly and 1 with congenital heart disease) received interferon-α. Among them, 3 showed regression of tumor and the remaining 1 showed decrease of tumor size. Two patients who suffered from severe heart failure received prednisolone and interferon-α, and then recovered. In the 2 patients with KM SD, we tried hepatic artery embolization with medical treatment. One survived but the other is not followed after failure of embolization.


We experienced that many patients who had clinical symptoms associated with HET very early in their life treated with an aggressive nonsurgical treatment in symptomatic patients showed favorable outcome.

Keywords: Infantile hepatic hemangioendothelioma; Neonate liver tumor; Kasabach-Merritt syndrome


Table 1
Clinical characteristics of infantile hepatic hemangioendothelioma
Click for larger image

Table 2
The clinical symptoms and treatment modality and response
Click for larger image

1. Dehner LP, Ishak KG. Vascular tumors of the liver in infants and children. A study of 30 cases and review of the literature. Arch Pathol 1971;92:101–111.
2. Stanley P, Gates GF, Eto RT, Miller SW. Hepatic cavernous hemangiomas and hemangioendotheliomas in infancy. AJR Am J Roentgenol 1977;129:317–321.
3. Dachman AH, Lichtenstein JE, Friedman AC, Hartman DS. Infantile hemangioendothelioma of the liver: a radiologic-pathologic-clinical correlation. AJR Am J Roentgenol 1983;140:1091–1096.
4. Kwon HJ, Moon SB, Park KW, Jung SE. Infantile hepatic hemangioendothelioma: seventeen years of experience at a single center. J Korean Assoc Pediatr Surg 2008;14:134–143.
5. Kim JH, Park YK, Choi CR, Lee C. A case report of hemangioendothelioma of the liver in an infant. J Korean Surg Soc 1968;10:519–522.
6. Daller JA, Bueno J, Gutierrez J, Dvorchik I, Towbin RB, Dickman PS, et al. Hepatic hemangioendothelioma: clinical experience and management strategy. J Pediatr Surg 1999;34:98–105.
7. Jackson C, Greene HL, O'Neill J, Kirchner S. Hepatic hemangioendothelioma. Angiographic appearance and apparent prednisone responsiveness. Am J Dis Child 1977;131:74–77.
8. Jung HJ, Yu JE, Pai KS, Ahn MS, Jung WC, Park MS, et al. Giant neonatal hemangioendothelioma of the liver diagnosed by 99mTc-RBC scintigraphy. J Korean Soc Neonatol 2005;12:105–111.
9. Roos JE, Pfiffner R, Stallmach T, Stuckmann G, Marincek B, Willi U. Infantile hemangioendothelioma. Radiographics 2003;23:1649–1655.
10. Zenge JP, Fenton L, Lovell MA, Grover TR. Case report: infantile hemangioendothelioma. Curr Opin Pediatr 2002;14:99–102.
11. Nguyen L, Shandling B, Ein S, Stephens C. Hepatic hemangioma in childhood: medical management or surgical management? J Pediatr Surg 1982;17:576–579.
12. Becker JM, Heitler MS. Hepatic hemangioendotheliomas in infancy. Surg Gynecol Obstet 1989;168:189–200.
13. Selby DM, Stocker JT, Waclawiw MA, Hitchcock CL, Ishak KG. Infantile hemangioendothelioma of the liver. Hepatology 1994;20:39–45.
14. Kim KU, Yoo SY, Cho MY. Two cases of infantile hemangioendothelioma of the liver. Korean J Gastroenterol 1993;25:1356–1361.
15. Holcomb GW 3rd, O'Neill JA Jr, Mahboubi S, Bishop HC. Experience with hepatic hemangioendothelioma in infancy and childhood. J Pediatr Surg 1988;23:661–666.
16. Goo JM, Kim WS, Kim IO, Yoon CH, Yeon KM, Choi CG. Infantile hemangioendothelioma of liver. J Korean Radiol Soc 1993;29:547–552.
17. Lucaya J, Enriquez G, Amat L, Gonzalez-Rivero MA. Computed tomography of infantile hepatic hemangioendothelioma. AJR Am J Roentgenol 1985;144:821–826.
18. Kim JS, Moon SK, Yoon HS, Lee TS. A case of infantile hemangioendothelioma of the liver treated with hepatic embolization and lobectomy. Korean J Pediatr 2005;48:660–664.
19. Weinreb JC, Cohen JM, Armstrong E, Smith T. Imaging the pediatric liver: MRI and CT. AJR Am J Roentgenol 1986;147:785–790.
20. Woltering MC, Robben S, Egeler RM. Hepatic hemangioendothelioma of infancy: treatment with interferon alpha. J Pediatr Gastroenterol Nutr 1997;24:348–351.
21. Park EA, Seo JW, Lee SW, Choi HY, Lee SJ. Infantile hemangioendothelioma treated with high dose methylprednisolone pulse therapy. J Korean Med Sci 2001;16:127–129.
22. van der Meijs BB, Merks JH, de Haan TR, Tabbers MM, van Rijn RR. Neonatal hepatic haemangioendothelioma: treatment options and dilemmas. Pediatr Radiol 2009;39:277–281.
23. Touloukian RJ. Hepatic hemangioendothelioma during infancy: pathology, diagnosis and treatment with prednisone. Pediatrics 1970;45:71–76.
24. Zweifach BW, Shorr E, Black MM. The influence of the adrenal cortex on behavior of terminal vascular bed. Ann N Y Acad Sci 1953;56:626–633.
25. Rocchini AP, Rosenthal A, Issenberg HJ, Nadas AS. Hepatic hemangioendothelioma: hemodynamic observations and treatment. Pediatrics 1976;57:131–135.
26. Yoon HS, Lee JH, Moon HN, Seo JJ, Im HJ, Goo HW. Successful treatment of retroperitoneal infantile hemangioendothelioma with Kasabach-Merritt syndrome using steroid, alpha-interferon, and vincristine. J Pediatr Hematol Oncol 2009;31:952–954.
27. Fok TF, Chan MS, Metreweli C, Ng PC, Yeung CK, Li AK. Hepatic haemangioendothelioma presenting with early heart failure in a newborn: treatment with hepatic artery embolization and interferon. Acta Paediatr 1996;85:1373–1375.
28. Friesel R, Komoriya A, Maciag T. Inhibition of endothelial cell proliferation by gamma-interferon. J Cell Biol 1987;104:689–696.
29. Folkman J. Successful treatment of an angiogenic disease. N Engl J Med 1989;320:1211–1212.
30. Fellows KE, Hoffer FA, Markowitz RI, O'Neill JA Jr. Multiple collaterals to hepatic infantile hemangioendotheliomas and arteriovenous malformations: effect on embolization. Radiology 1991;181:813–818.